A PYMNTS Company

Pharma Firms

China Watchdog Fines Two Pharma Firms
By  |  May 30, 2023

According to Reuters, two pharmaceutical companies were fined by China’s market regulator for engaging in monopolistic behavior. Grand Pharmaceutical was fined 136 million yuan ($19.68 million) and had 149 million yuan of “illegal revenue” confiscated for engaging in a monopolistic agreement with Wuhan Healthcare Pharmaceuticals. Related: UK: CMA accuses pharma firms of market allocation Wuhan […]

Loading...

Featured News

South Korean Steelmaker POSCO Expands Supplier Support Pact With Antitrust Regulator
Jul 16, 2026 by

FCC’s Carr Criticizes California-Led Bid to Block Paramount-Warner Bros. Discovery Deal
Jul 16, 2026 by

EU Top Court Upholds Antitrust Powers to Seize Corporate Emails
Jul 16, 2026 by

Uber Launches $14.8 Billion Bid for Delivery Hero in Landmark Food Delivery Deal
Jul 16, 2026 by

EU Orders Google to Open Android and Search Data to Rival AI Services
Jul 16, 2026 by

Antitrust Mix

Antitrust Chronicle® – Agentic AI & Antitrust
Jul 16, 2026 by

AI Agents and Collusion: The Two Faces of Agentic AI
Jul 16, 2026 by Giovanna Massarotto

Agentic AI’s Regulatory Conundrum
Jul 16, 2026 by Anant Raut

Inter-AI-Agent Competition
Jul 16, 2026 by Stefan Thomas

Navigating the Increasing Regulatory Scrutiny of AI-Pricing Tools: Competition and Other Emerging Risks
Jul 16, 2026 by Mark Krotoski & Vinny Sidhu